Three people were charged with conspiring with others to have unqualified people admitted to skilled nursing homes and assisted living facilities. » Read More
The medical community is breathing new life into Google Glass.
Apple's software update this fall will make it easier for people to register as organ donors, the Verge reports.
The new 11.1 million tally comes as some insurers are proposing double-digit percentage hikes for health plans next year.
If regulators block Anthem's merger with Cigna, the insurance companies may be better off just walking away, analysts said.
The average national cost for a routine vaginal delivery is $8,775, and $11,525 for c-sections.
The FDA issued a statement warning people not to eat cookie dough due to a recent string of E.coli outbreaks associated with some batches of flour.
Just 13 percent of people said they personally viewed Zika as a major threat, but most knew it is dangerous to pregnant women.
The country is now effectively evenly split when it comes to how the Affordable Care Act is viewed.
Niraparib was shown to extend the time elapsed between treatment of ovarian cancer and tumor progression.
Two vaccines for Zika protected against two common strains of the virus in mice, and will enter human trials soon.
AstraZeneca is trying to fend off generic competition to Crestor by getting it approved to treat a rare disease, NYT reported.
Stifel Nicolaus started coverage on Cigna with a buy rating and a $169 target on shares, based on the current Anthem deal value.
The research could lead to the development of new medical sensors that can warn patients about potential symptoms.
The drug, a treatment option for people with Lennox-Gastaut syndrome, has been shown to reduce the number of monthly seizures in some patients.
Legendary has won the rights to "Bad Blood," a film about Theranos, according to The Hollywood Reporter.
Health regulators are proposing to make some Medicare drug payments based on how well those medications work for patients.
A common way of using smartphones fooled two women into thinking they were going blind.
Biotech stocks rallied after a government report said that Medicare cost-cutting measures will not be triggered this year.
Shares of Actuant plummeted more than 7 percent after the company released its fiscal third-quarter earnings.
U.S. House of Representatives Speaker Paul Ryan unveiled a Republican agenda that would repeal Obamacare but keep some of its more popular provisions.
Get the best of CNBC in your inbox